“How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS)” (2019) Brazilian Journal of Pharmaceutical Sciences, 55, p. e17197. doi:10.1590/s2175-97902019000117197.